Madrid Auditorium (Hall 2) Special symposium

Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)

Date
30.09.2019
Time
10:15 - 11:45
Location
Madrid Auditorium (Hall 2)
Chairs
  • Joaquim Bellmunt (Boston, MA, United States of America)
  • Eva Comperat (Paris, France)
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Introduction (ID 220)

Lecture Time
10:15 - 10:20
Speakers
  • Eva Comperat (Paris, France)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Single agent immune therapy and immune combinations (ID 216)

Lecture Time
10:20 - 10:40
Speakers
  • Joaquim Bellmunt (Boston, MA, United States of America)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Immune therapy in combination with chemotherapy (ID 219)

Lecture Time
10:40 - 11:00
Speakers
  • Arlene O. Siefker-Radtke (Houston, TX, United States of America)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Immune therapy in combination with targeted therapy (ID 217)

Lecture Time
11:00 - 11:20
Speakers
  • Yohann Loriot (Villejuif, France)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Biomarkers beyond PD-L1 expression to predict outcome to immune therapy (ID 218)

Lecture Time
11:20 - 11:40
Speakers
  • Michiel S. Van der Heijden (Amsterdam, Netherlands)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45
Selecting and sequencing therapy in previously untreated urothelial cancer Special symposium

Conclusions and perspectives (ID 221)

Lecture Time
11:40 - 11:45
Speakers
  • Joaquim Bellmunt (Boston, MA, United States of America)
Session Name
Selecting and sequencing therapy in previously untreated urothelial cancer
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:15 - 11:45